Purchase Order 36C24424P0358
Award Date 2/29/24
Potential Completion Date 3/1/24
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, was made by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) for the delivery of specialty pharmaceutical products. The contract, valued at $138,543.43, is a firm fixed price purchase order without any set-aside designation. Accredo, as the prime contractor, provides specialty medications directly to VA medical centers and facilities across the country to...
- Accredo Health Group, Inc. was awarded a firm fixed price purchase order without set aside designation from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6. The contract has a potential value of $154,457.60 and a completion date of January 23, 2024. As the prime contractor, Accredo Health Group will provide OXERVATE medicine to the VA medical center located in Bartlett, Tennessee. As a pharmacy benefit management company specializing in...
- Accredo Health Group, Inc., a specialty pharmacy benefit management company and subsidiary of Express Scripts, received a federal contract award from Veterans Integrated Service Network 19 (VISN 19) on January 8, 2026. This purchase order, valued at $11,197.82 with a firm fixed-price structure, requires delivery of pharmaceutical products to the VA facility in Bartlett, Tennessee, with completion expected by January 11, 2026. No set-aside designation was applied to this award. The contract...
- This federal contract award, with the ID VA25917E0551, was issued by the Department of Veterans Affairs (VA) to the prime contractor Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The award consists of 13 firm fixed-price purchase orders totaling $108,039.41, with an ultimate completion date of September 30, 2016. The contract does not have a set-aside designation. Accredo Health Group, Inc. has been a long-standing...
- This is a $103,003.20 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract is for the delivery of various complex and high-value medications, primarily to support the VA's Veterans Integrated Service Network (VISN) healthcare facilities. Key medications provided under this contract include drugs used to treat...
- This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the delivery of the specialty pharmaceutical DUOPA. The $10,122.32 contract has a completion date of May 7, 2025 and was awarded on February 7, 2025 with no set-aside designation. Accredo Health Group, Inc., a subsidiary of Express Scripts, is a key distributor of complex and high-value medications, primarily...
- Accredo Health Group, Inc. was awarded a firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23, valued at $64,907.10, to provide a six month supply of Palynziq 20mg injections for emergency medication orders. Performance will take place at Accredo's distribution center in Bartlett, Tennessee, with no set aside designation used. As a prime contractor supporting the VHA through national contracts and regional...
- The U.S. Department of Veterans Affairs (VA) awarded a $43,162 firm fixed-price purchase order to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical Prolastin. This contract is not associated with a set-aside program and has an ultimate completion date of June 30, 2024. Accredo Health Group, Inc., a subsidiary of Express Scripts, is a key distributor of complex and high-value medications, primarily serving the healthcare needs of...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Accredo Health Group, Inc., a pharmacy benefit management company that provides specialty pharmacy services and distribution of specialty pharmaceuticals. The contract is for the delivery of chemotherapy medications for 3 patients, with 4 doses each, with a potential value of $103,800.00. The contract does not have a set-aside designation. As a prime contractor...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 21 to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the delivery of the specialty pharmaceutical Tyvaso. The total ceiling value of the contract is $81,342.18, with a period of performance through September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and high-value medications, primarily serving the...